RMEA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Resmed Inc

Watchlist Manager

Watchlist

Price: 20.8 EUR -3.7% Market Closed

Market Cap: €30.6B

	Resmed Inc F:RMEA	US
	Iress Ltd ASX:IRE	AU
A	Asian Phytoceuticals PCL SET:APCO	TH
	J B Hunt Transport Services Inc NASDAQ:JBHT	US
B	biote Corp NASDAQ:BTMD	US
	WPP PLC LSE:WPP	UK
	Iberdrola SA OTC:IBDRY	ES

Profitability Summary

Resmed Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

61%

Strong 3Y Average Gross Margin

59%

Gross Margin is Increasing

55% > 61%

Exceptional Operating Margin

34%

Strong 3Y Average Operating Margin

32%

Operating Margin is Increasing

27% > 34%

Healthy Net Margin

27%

Sustainable 3Y Average Net Margin

25%

Net Margin is Increasing

21% > 27%

Exceptional Free Cash Flow Margin

29%

Strong 3Y Average Free Cash Flow Margin

29%

Free Cash Flow Margin is Increasing

18% > 29%

Positive ROE

24%

Positive 3Y Average ROE

Positive 3Y Average ROIC

20%

ROIC is Increasing

17% > 22%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.